Company News

Peak Proteins Company News Archives

FEN1-inhibitor co-crystal structure published

2016-08-17T16:11:14+00:00August 17th, 2016|Company News|

Mark Abbott has recently co-authored a paper in Nature Chemical Biology  as part of a collaboration between AstraZeneca, University of Sheffield and Pelago BioSciences. The publication describes the co-crystal structure of flap endonuclease 1 (FEN1) bound with small molecule inhibitors and describes [...]

Go to Top